[ad_1]
Uguras Sahinas. Photo by Fabiano Bimmerio (Reuters / Scanpix)
The positive effects of the COVID-19 vaccine should be felt next summer and normal life will return next year, predicts the BBC Ugur Sahin, CEO of BioNTech. At least your company together with Pfizer announced that it has made significant progress in the crime of COVID-19.
Mr. Sahin cautions that ingestion will remain serious and that the vaccine has no established effect on the growth of COVID-19.
V recalls that last week BioNTech and Pfizer announced that phase III clinical trials had shown that the COVID-19 vaccine developed by the company was more than 90% effective.
The efficacy of the vaccine was confirmed in phase III clinical trials, in which the vaccine was tested in 43,000 volunteers. After two doses administered 28 days apart, the small amount of infected virus allowed evaluators to estimate the effectiveness of the vaccine.
Palkti text
The vaccine will be administered mainly to healthcare professionals and the elderly. In an interview with the UK broadcaster, Sahin said he was confident that the vaccine would reduce the spread of COVID-19 and that the vaccine would prevent COVID-19 symptoms.
I am absolutely sure that the spread of the virus, if not the absence of 90%, but at least 50% of the assets, requires a major change in the management of the pandemic, Sahin said.
A BioNTech spokesperson said that if things went according to plan, the vaccine could be available by the end of the year or early next.
BioNTech and Pfizer aim to deliver more than $ 300 million worldwide. the vaccine dose before April of next year. According to Sahin, as soon as the vaccine reaches the states, only then will the vaccine start working against COVID-19.
However, according to the director of BioNTech, the real effect of the vaccine will be felt later.
Next summer will be very useful for us, because we will definitely have a little time for the summer. It will be very important that we can vaccinate large numbers of people for the upcoming fall / winter season, says the BBC, Mr Sahin.
The European Union (EU) has agreed to buy up to € 300 million from Pfizer and BioNTech, which have reached COVID-19. dose of vaccine.
Once the vaccine has been shown to be safe and effective in combating COVID-19, Member States will be able to purchase € 200 million under the agreement. dose of vaccine. It is also possible to buy an additional 100 million. dose.
Rayti komentar
[ad_2]
